35203613|t|Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice.
35203613|a|Glucocorticoids (GCs) are widely used to treat inflammatory diseases. However, their long-term use leads to glucocorticoid-induced osteoporosis, increasing morbidity and mortality. Both anabolic and anti-resorptive drugs are used to counteract GC-induced bone loss, however, they are expensive and/or have major side effects. Therefore, identifying new targets for cost-effective, small-molecule inhibitors is essential. We recently identified cyclin-dependent kinase 5 (Cdk5) as a suppressor of osteoblast differentiation and showed that its inhibition with roscovitine promoted osteoblastogenesis, thus improving the skeletal bone mass and fracture healing. Here, we assessed whether Cdk5 knockdown or inhibition could also reverse the GC-mediated suppression of osteoblast differentiation, bone loss, and fracture healing. We first demonstrated that Cdk5 silencing abolished the dexamethasone (Dex)-induced downregulation of alkaline phosphatase (Alp) activity, osteoblast-specific marker gene expression (Runx2, Sp7, Alpl, and Bglap), and mineralization. Similarly, Cdk5 inhibition rescued Dex-induced suppression of Alp activity. We further demonstrated that Cdk5 inhibition reversed prednisolone (Pred)-induced bone loss in mice, due to reduced osteoclastogenesis rather than improved osteoblastogenesis. Moreover, we revealed that Cdk5 inhibition failed to improve Pred-mediated impaired fracture healing. Taken together, we demonstrated that Cdk5 inhibition with roscovitine ameliorated GC-mediated bone loss but did not reverse GC-induced compromised fracture healing in mice.
35203613	14	18	Cdk5	Gene	12568
35203613	40	49	Bone Loss	Disease	MESH:D001847
35203613	76	80	Mice	Species	10090
35203613	129	150	inflammatory diseases	Disease	MESH:D007249
35203613	213	225	osteoporosis	Disease	MESH:D010024
35203613	337	346	bone loss	Disease	MESH:D001847
35203613	526	551	cyclin-dependent kinase 5	Gene	12568
35203613	553	557	Cdk5	Gene	12568
35203613	641	652	roscovitine	Chemical	MESH:D000077546
35203613	724	732	fracture	Disease	MESH:D050723
35203613	768	772	Cdk5	Gene	12568
35203613	820	822	GC	Disease	
35203613	875	884	bone loss	Disease	MESH:D001847
35203613	890	898	fracture	Disease	MESH:D050723
35203613	935	939	Cdk5	Gene	12568
35203613	964	977	dexamethasone	Chemical	MESH:D003907
35203613	979	982	Dex	Chemical	MESH:D003907
35203613	1091	1096	Runx2	Gene	12393
35203613	1098	1101	Sp7	Gene	170574
35203613	1103	1107	Alpl	Gene	11647
35203613	1113	1118	Bglap	Gene	12096
35203613	1152	1156	Cdk5	Gene	12568
35203613	1176	1179	Dex	Chemical	MESH:D003907
35203613	1246	1250	Cdk5	Gene	12568
35203613	1271	1283	prednisolone	Chemical	MESH:D011239
35203613	1285	1289	Pred	Chemical	MESH:D011239
35203613	1299	1308	bone loss	Disease	MESH:D001847
35203613	1312	1316	mice	Species	10090
35203613	1420	1424	Cdk5	Gene	12568
35203613	1454	1458	Pred	Chemical	MESH:D011239
35203613	1477	1485	fracture	Disease	MESH:D050723
35203613	1532	1536	Cdk5	Gene	12568
35203613	1553	1564	roscovitine	Chemical	MESH:D000077546
35203613	1589	1598	bone loss	Disease	MESH:D001847
35203613	1619	1621	GC	Disease	
35203613	1642	1650	fracture	Disease	MESH:D050723
35203613	1662	1666	mice	Species	10090
35203613	Positive_Correlation	12393	12568
35203613	Negative_Correlation	MESH:D011239	MESH:D050723
35203613	Negative_Correlation	MESH:D000077546	MESH:D050723
35203613	Negative_Correlation	MESH:D003907	170574
35203613	Association	MESH:D011239	12568
35203613	Positive_Correlation	12096	12568
35203613	Negative_Correlation	MESH:D000077546	12568
35203613	Positive_Correlation	11647	12568
35203613	Positive_Correlation	MESH:D011239	MESH:D001847
35203613	Negative_Correlation	MESH:D000077546	MESH:D001847
35203613	Negative_Correlation	MESH:D003907	12393
35203613	Negative_Correlation	MESH:D003907	12096
35203613	Positive_Correlation	12568	170574
35203613	Negative_Correlation	MESH:D003907	11647
35203613	Association	MESH:D003907	12568
35203613	Association	MESH:D001847	12568

